top of page
biologic pharmamedical_photo (6).png

ADVANCED CURCUMIN CHOLESTEROL TECHNOLOGY

CURCUMIN-LDL45™ engineered curcumin for LDL-cholesterol + heart health.

CURCUMIN-LDL45™ is an advanced curcumin formulation featuring 45% cholesterol-correcting curcuminoids, compared with 12% in regular extracts. Designed to manage LDL-cholesterol, reduce oxidative stress, and inhibit inflammation, it provides a differentiated platform for cardiovascular and cholesterol-focused wellness products.

Biologic Pharmamedical_CurcuminLDL45
ChatGPT Image Sep 17, 2026, 04_01_14 PM.png

WHY IT'S DIFFERENT

A cardiovascular curcumin technology built beyond generic lipid support

45% cholesterol-correcting curcuminoids

CURCUMIN-LDL45™ contains 45% cholesterol-correcting curcuminoids, compared with 12% in regular extracts, providing a differentiated curcumin platform for LDL-focused formulations.

Targets serum LDL

CURCUMIN-LDL45™ is designed to help scavenge serum LDL and reduce LDL synthesis, addressing cholesterol management from multiple pathways.

Powerful antioxidant activity

Its antioxidant activity helps protect serum LDL from oxidation, which the supplied material identifies as a process involved in atherosclerotic plaque development.

Anti-inflammatory support

CURCUMIN-LDL45™ provides anti-inflammatory activity intended to help mitigate immune-mediated advancement of plaque development, supporting formulations focused on heart and cardiovascular health.

biologic pharmamedical_photo (7).png

Ready to Differentiate?

Put CURCUMIN-LDL45™ into your next heart-health product

CURCUMIN-LDL45™ to support product development focused on LDL-cholesterol management, antioxidant protection, inflammation, and heart health.

Need formulation, manufacturing or regulatory support?

Explore how Biologic can help bring your concept to market.

Copy of Untitled Design.png

Contact Us

Connect With Our Team

Thank you for joining Biologic News!

Suite 1100, 1200 West 73rd Street,Vancouver, BC, V6P 6G5

1.855.518.8858 |  604.684.9321

CANADA | US

bottom of page